Dentsply Sirona (XRAY) Tops Q3 EPS by 3c ; Offers Guidance

Dentsply Sirona (NASDAQ: XRAY) reported Q3 EPS of $0.50, $0.03 better than the analyst estimate of $0.47. Revenue for the quarter came in at $951 million versus the consensus estimate of $937.91 million.

GUIDANCE:

Dentsply Sirona sees FY2024 EPS of $1.82-$1.86, versus the consensus of $1.98.

For earnings history and earnings-related data on Dentsply Sirona (XRAY) click here.

You May Also Be Interested In

• Apollo Global Management (APO) call put ratio 1 call to 6.8 puts a focus on a spreader of 9K contracts January 95 and 135 puts
• AeroVironment restates quarterly financials, citing $89M goodwill error
• EU approves AbbVie's Skyrizi for children with plaque psoriasis